Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IsoPSA® in vitro ...
A large new study using advanced imaging found that abdominal obesity, sometimes referred to as a "beer belly," is associated with more harmful changes in heart structure than overall body weight ...
Whether you’re shopping for the impending holidays, picking up some birthday gifts or simply want to snag everyday household ...